EPIM
BSX icon

Evelyn Partners Investment Management’s Boston Scientific BSX Stock Holding History

Evelyn Partners Investment Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.6M Buy
168,771
+26,883
+19% +$2.15M 0.29% 58
2025
Q4 		$13.5M Buy
141,888
+15,353
+12% +$1.51M 0.37% 52
2025
Q3 		$12.4M Buy
126,535
+121,913
+2,638% +$12.6M 0.35% 54
2025
Q2 		$496K Buy
4,622
+3,282
+245% +$332K 0.02% 164
2025
Q1 		$135K Hold
1,340
– – ﹤0.01% 219
2024
Q4 		$120K Buy
+1,340
New +$118K ﹤0.01% 223

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Evelyn Partners Investment Management's BSX Position: Q1 2026 in Review

Evelyn Partners Investment Management increased its Boston Scientific (BSX) stake by 19% in Q1 2026, buying an estimated $2.15M and bringing the position to 168,771 shares worth $10.6M. The position accounts for 0.29% of the portfolio, ranked #58.

Evelyn Partners Investment Management first reported a position in BSX in Q4 2024 and has held it in 6 quarters since. The position peaked at $13.5M in Q4 2025. 1,683 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Evelyn Partners Investment Management held 168,771 shares of Boston Scientific worth $10.6M as of Q1 2026.
  • Evelyn Partners Investment Management bought 26,883 Boston Scientific shares in Q1 2026, an estimated $2.15M.
  • Boston Scientific made up 0.29% of Evelyn Partners Investment Management's portfolio in Q1 2026, its #58 holding.
  • Evelyn Partners Investment Management first reported a position in Boston Scientific in Q4 2024 and has held it in 6 quarters since.
  • Evelyn Partners Investment Management's Boston Scientific position peaked at $13.5M in Q4 2025.
  • 1,683 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Evelyn Partners Investment Management's 13F filing for Q1 2026, filed 15 May 2026.